HomeComparePNNT vs HRC

PNNT vs HRC: Dividend Comparison 2026

PNNT yields 21.82% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PNNT wins by $2484.87M in total portfolio value
10 years
PNNT
PNNT
● Live price
21.82%
Share price
$4.40
Annual div
$0.96
5Y div CAGR
57.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2487.12M
Annual income
$2,270,557,040.91
Full PNNT calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — PNNT vs HRC

📍 PNNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPNNTHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PNNT + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PNNT pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PNNT
Annual income on $10K today (after 15% tax)
$1,854.55/yr
After 10yr DRIP, annual income (after tax)
$1,929,973,484.77/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, PNNT beats the other by $1,928,763,569.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PNNT + HRC for your $10,000?

PNNT: 50%HRC: 50%
100% HRC50/50100% PNNT
Portfolio after 10yr
$1244.69M
Annual income
$1,135,990,235.27/yr
Blended yield
91.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HRC right now

PNNT
Analyst Ratings
3
Buy
11
Hold
1
Sell
Consensus: Hold
Price Target
$6.17
+40.2% upside vs current
Range: $5.50 — $7.00
Altman Z
-0.1
Piotroski
6/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PNNT buys
0
HRC buys
0
No recent congressional trades found for PNNT or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPNNTHRC
Forward yield21.82%11.38%
Annual dividend / share$0.96$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.6%40.3%
Portfolio after 10y$2487.12M$2.26M
Annual income after 10y$2,270,557,040.91$1,423,429.65
Total dividends collected$2470.97M$2.14M
Payment frequencyquarterlyquarterly
SectorBDCStock
Analyst consensusHoldHold

Year-by-year: PNNT vs HRC ($10,000, DRIP)

YearPNNT PortfolioPNNT Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$14,139$3,438.55$12,296$1,595.93+$1.8KPNNT
2$22,289$7,160.64$15,730$2,573.05+$6.6KPNNT
3$40,476$16,626.77$21,147$4,316.00+$19.3KPNNT
4$87,781$44,472.18$30,235$7,608.15+$57.5KPNNT
5$235,984$142,058.38$46,615$14,263.36+$189.4KPNNT
6$815,001$562,497.15$78,712$28,834.27+$736.3KPNNT
7$3,733,376$2,861,325.49$148,063$63,841.01+$3.59MPNNT
8$23,300,323$19,305,611.09$315,890$157,462.80+$22.98MPNNT
9$202,397,772$177,466,426.06$778,498$440,495.17+$201.62MPNNT
10$2,487,122,657$2,270,557,040.91$2,256,422$1,423,429.65+$2484.87MPNNT

PNNT vs HRC: Complete Analysis 2026

PNNTBDC

PennantPark Investment Corporation, a business development company is a private equity fund specializes in direct and mezzanine investments in middle market companies. It invests in the form of mezzanine debt, senior secured loans, and equity investments. The fund typically invests in buildings and real estate, hotels, gaming and leisure, technology, telecommunications, transportation, information technology services, electronics, healthcare & pharmaceuticals, education and childcare, financial services, printing and publishing, consumer products, business services, energy & Related Services and utilities, distribution, oil and gas, media, environmental services, aerospace and defense, building materials, capital equipment, chemicals, plastics, & rubber, food & beverage, wholesale, manufacturing and basic industries and retail. It invests in equity securities and debt transactions through preferred stock, common stock, warrants, options, senior secured debt, subordinated debt, subordinated loans, first lien debt, mezzanine loans, and distressed debt securities and private equity co-investments. It seeks to invest in companies based in the United States. The fund seeks to invest between $10 million and $100 million cross the capital structure (senior secured loans, subordinated debt, and other investments) in its portfolio companies with EBITDA between $10 to $50 million. Its mezzanine loans, senior secured loans, and other investments in its portfolio companies are between $15 million and $50 million. The fund may also make non-control equity and debt investments.

Full PNNT Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this PNNT vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PNNT vs SCHDPNNT vs JEPIPNNT vs OPNNT vs KOPNNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.